Ocular Therapeut (NQ: OCUL )
8.605
-0.125
(-1.43%)
Streaming Delayed Price
Updated: 12:32 PM EDT, Aug 20, 2024
Add to My Watchlist
All News about Ocular Therapeut
![](https://mms.businesswire.com/media/20220425005249/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/04/17/biotech11.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220414005882/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2119.jpeg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_2659.jpeg?width=720)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_7009.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_6909.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2169.jpeg)
![](https://mms.businesswire.com/media/20220222005137/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://mms.businesswire.com/media/20220211005129/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_2810.jpeg)
![](https://mms.businesswire.com/media/20220118005422/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://mms.businesswire.com/media/20220104005292/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2744.png)
![](https://mms.businesswire.com/media/20211206005259/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://mms.businesswire.com/media/20211115005512/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
Ocular Therapeutix™ to Participate at Two Upcoming Investor Conferences
November 15, 2021
Via Business Wire
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2440.png?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_4081.jpeg)
![](https://mms.businesswire.com/media/20211109006077/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/earnings_image_683.jpeg)
![](https://mms.businesswire.com/media/20211108006032/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://mms.businesswire.com/media/20211105005537/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/earnings_image_631.jpeg)
![](https://mms.businesswire.com/media/20211101005314/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://mms.businesswire.com/media/20211029005481/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
Ocular Therapeutix™ To Report Third Quarter 2021 Financial Results
October 29, 2021
Via Business Wire
![](https://mms.businesswire.com/media/20211028005405/en/807582/5/OCUTX_Logo_RGB_1200x700_FINAL.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_1889.jpeg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/stock-exchange-4785080_1920_13.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/price_targets_302.png?width=720)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.